logo

Opgen, Inc. (OPGN)



Trade OPGN now with
  Date
  Headline
4/5/2022 7:39:21 AM OpGen Announces Interim Analysis Results From Clinical Trial For Unyvero Urinary Tract Infection Panel
6/7/2021 7:38:53 AM OpGen Submits Updated 510(k) Summary To FDA For Acuitas AMR Gene Panel For Isolates
1/13/2021 7:35:02 AM OpGen Q4 Revenue $1.3 Mln Vs $0.8 Mln Last Year